Cardinal Health (CAH) - FREE Research Report

Watkins Carole S who is Chief HR Officer at Cardinal Health sold 28,260 shares at $67.01 on Feb. 11, 2014. Following this transaction, the Chief HR Officer owned 25,284 shares meaning that the stake was reduced by 52.78% with the 28,260-share transaction.

Blake Mark R who is EVP - Strategy & Corp. Dev. at Cardinal Health sold 2,330 shares at $68.53 on Feb. 11, 2014. Following this transaction, the EVP - Strategy & Corp. Dev. owned 31,941 shares meaning that the stake was reduced by 6.8% with the 2,330-share transaction.

The shares most recently traded at $70.28, up $1.75, or 2.49% since the insider transaction. Historical insider transactions for Cardinal Health go as follows:

  • 4-Week # shares sold: 56,269
  • 12-Week # shares sold: 56,269
  • 24-Week # shares sold: 57,258

The average volume for Cardinal Health has been 2.6 million shares per day over the past 30 days. Cardinal Health has a market cap of $22.9 billion and is part of the services sector and wholesale industry. Shares are up 4.12% year-to-date as of the close of trading on Tuesday.

Cardinal Health, Inc., a healthcare services company, provides pharmaceutical and medical products and services in the United States and internationally. The company operates in two segments, Pharmaceutical and Medical. The stock currently has a dividend yield of 1.82%. The company has a P/E ratio of 61.2. Currently there are 11 analysts that rate Cardinal Health a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CAH - FREE

TheStreet Quant Ratings rates Cardinal Health as a buy. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Cardinal Health Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Gun Stocks Plummet on Sales Decline; Insurers Rebound to End the Week - ICYMI

Stocks Finish Mixed as Hurricane Irma Barrels Toward Florida Coast

Dow Rallies as Travelers Rebounds but Rest of Market Trails Ahead of Irma

Wall Street Turns Mixed as Hurricane Irma Watch Keeps Trading Cautious

Stock Futures Point Lower as Hurricane Irma Barrels Toward Florida